Deciphering Urogenital Cancers through Proteomic Biomarkers: A Systematic Review and Meta-Analysis
Open Access
Abstract
Urogenital cancers, which include prostate, bladder, and kidney malignancies, exert a substantial impact on global cancer-related morbidity and mortality. Proteomic biomarkers, emerging as valuable tools, aim to enhance early detection, prognostic accuracy, and the development of personalized therapeutic strategies. This study undertook a comprehensive systematic review and meta-analysis of the existing literature investigating the role and potential of proteomic biomarkers in plasma, tissue, and urine samples in urogenital cancers. Our extensive search across several databases identified 1879 differentially expressed proteins from 37 studies, signifying their potential as unique biomarkers for these cancers. A meta-analysis of the significantly differentially expressed proteins was executed, accentuating the findings through visually intuitive volcano plots. A functional enrichment analysis unveiled their significant involvement in diverse biological processes, including signal transduction, immune response, cell communication, and cell growth. A pathway analysis highlighted the participation of key pathways such as the nectin adhesion pathway, TRAIL signaling pathway, and integrin signaling pathways. These findings not only pave the way for future investigations into early detection and targeted therapeutic approaches but also underscore the fundamental role of proteomics in advancing our understanding of the molecular mechanisms underpinning urogenital cancer pathogenesis. Ultimately, these findings hold remarkable potential to significantly enhance patient care and improve clinical outcomes.Keywords
This publication has 49 references indexed in Scilit:
- Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinomaJournal of Proteomics, 2013
- An Integrative Proteomics and Interaction Network-Based Classifier for Prostate Cancer DiagnosisPLOS ONE, 2013
- Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancersNature Reviews Urology, 2013
- Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor geneCancer and Metastasis Reviews, 2012
- The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuriaCancer, 2011
- Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancerCancer Letters, 2008
- Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinomaProteomics, 2008
- Detection of pre-neoplastic and neoplastic prostate disease by MADI profiling of urineBiochemical and Biophysical Research Communications, 2006
- High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicityOncogene, 2003
- Evidence for a Novel Gene Associated With Low Tumor Metastatic PotentialJNCI: Journal of the National Cancer Institute, 1988